Together, these data suggest that in heterogeneous non-NE/NE SCLC tumors, fractional killing via ferroptosis may select for NE cells over time while, vice versa, TRX pathway inhibition might enrich tumors for non-NE SCLC cells. Here, TXN is linked to small cell lung carcinoma.